Skip to main content
. Author manuscript; available in PMC: 2015 May 13.
Published in final edited form as: Vaccine. 2014 Mar 26;32(23):2696–2702. doi: 10.1016/j.vaccine.2014.03.046

Fig. 2.

Fig. 2

Comparison of rOv-ASP-1 and alum in inducing influenza-specific antibody responses after primary immunization with influenza vaccine. B6 mice were vaccinated with 0.3 μg of TIV alone or TIV combined with 20 μg rOv-ASP-1 or 1.2 mg alum. Titers of influenza-specific antibodies (IgG, IgG1, and IgG2c) in plasma at week 2 after immunization were determined by ELISA using TIV as antigen. Data is the combination of up to 6–12 mice/group from 2–3 independent experiments with similar results. * p < 0.05.